Post by
jermiah777 on Jul 09, 2021 12:25pm
Future
The analysis report that gave a 2.25 target price for Willow assumed that their would be other manufacturers providing biosynthetic molecules. The main issue is that biosynthetically production becomes the choice of pharmaceutical companies . If that happens and the world market for CBG and other molecules picks up, their is plenty of room for more than one supplier.
I find it fascinating how quickly public perception can change. Only a few months ago, millions of shares were sold to institutional investors at 1.65. Also about 9 million warrants were exercised for 85 cents. But the warrantys prior to being exercised were selling between 7c and 1.20. So perhaps an average price of the warrants would be 45 cents. So we could say 9 million of the shares were purchased for 1.30 This stock went down to 30 cents last year. It was pretty depressing. In a little over half a year it went up to as high as 2.25 That is almost 8 times gain in about 7 months. So, is the 99 cent range the new LOW from a year ago? Lalani Sadiq bought 30000 on the common market about a week ago. Likely he wouldn't do that if he was actually concerned it could drop significantly more. To me the volumes are low enough that it is possible to simply beat down the price to scare the retail investor. Who wants to buy now? Seriously, how many are buying today? But not many selling either. I just find it hard to believe this could drop much further. If I could venture a guess, regardless of where the low turns out to be, the share price in the fall time will be significantly higher than now. Time will tell....it always does....